绍兴治成人紫癜的医院合肥过敏性紫癜怎么治能除根,淮安哪家医院看过敏性紫癜最好,安徽紫癜要怎么治疗,合肥治疗儿童紫癜的医院,合肥紫癜最好治疗方法,连云港过敏性紫癜的最佳治疗方案,萍乡哪里医院治疗过敏性紫癜好

BEIJING, Oct. 26 (Xinhuanet) -- The question, why the first documented supernova was super-sized and grew so fast, has puzzled astronomers for centuries. Now it is solved by US researchers.The supernova, an exploded star, was observed in 185 A.D. and documented as a mysterious "guest star" by Chinese astronomers. It was visible for eight months.Scientists later found the supernova, 8,000 light years away, was a bigger-than-expected supernova remnant. BBC reported that if the infrared light it emits could be seen by human eyes, it would appear to be as large as the full Moon in the sky.Through observations in space telescopes, researchers of a latest study revealed that the explosion took place in a cavity in space, which allowed the star's remains to travel out much faster and farther. The study was published online in the Astrophysical Journal Monday.The supernova was "two to three times bigger than we would expect for a supernova that was witnessed exploding nearly 2,000 years ago. Now, we've been able to finally pinpoint the cause," stated Brian Williams, lead author of the study and an astronomer at North Carolina State University in Raleigh.

SAN FRANCISCO, Dec. 9 (Xinhua) -- Apple on Friday suffered a major setback in its global patent war, as a German court ruled over its copyright infringement battle in favor of Motorola Mobility.The German court ruled that Apple's iPhone and iPad infringe a Motorola patent and issued an injunction banning the import of iPhones and 3G-capable iPads into Germany.The dispute, one of Apple's several patent lawsuits around the world, is over a Motorola patent essential to GPRS. Motorola has been negotiating with Apple over licensing terms and conditions since 2007, and it will continue its efforts to resolve its global patent dispute as soon as practicable, said Motorola Mobility in a statement on Friday."We're going to appeal the court's ruling right away. Holiday shoppers in Germany should have no problem finding the iPad or iPhone they want," an Apple spokesman told tech news site AllThingsD.Apple is not too concerned about losing out in the Christmas shopping season as it has plenty of iPhones and iPads in Germany already, AllThingsD cited unidentified sources as saying.The ruling is against Apple's European sales company and only impacts its products sold in Germany. The German court also ruled that Motorola is entitled to a damages award.Apple can appeal the ruling to a higher court and request a stay of the injunction, according to a blog post of Florian Mueller, a U.S. patent expert who has been closely following patent lawsuits in the mobile industry.Mueller said should Apple make the appeal but the court declines the stay, Motorola must post a 100 million euro (around 134 million U.S. dollars) bond before the court will enforce the injunction.In August, Apple also filed a suit in Germany over the design of Motorola's tablet Xoom, which runs Google's Android system. But Apple did not make it clear whether it will seek to block the sales of Xoom in Europe.Also on Friday, Samsung won an appeal from the Australian High Court overturning a previous Apple victory that effectively banned Samsung from selling its Galaxy Tab in Australia.Based on claims of infringing Apple's patents, the Cupertino, California-based tech giant has been seeking court order to block Samsung's Galaxy line of mobile devices around the world.A German court issued an injunction in August, blocking Samsung from selling its Galaxy Tab 10.1 tablets across all European Union members, except for the Netherlands.On Thursday, Apple said it will appeal a San Jose, California judge's refusal to ban sales of Samsung 4G smartphones and Galaxy Tab 10.1 tablets in the United States.

BEIJING, Oct. 7 (Xinhua) -- Chinese scientists are developing new methods like spraying or dropping hepatitis vaccines into people's noses to replace traditional injections, according to a leading expert on immunology.Such researches were sponsored by a key national science project, according to Wen Yumei, an academician of the Chinese Academy of Engineering, also the chairwoman of the 14th International Symposium on Viral Hepatitis and Liver Disease, which is scheduled to be held in Shanghai next July.At a press conference held here Friday for the symposium, experts believed that broad-coverage inoculations is an effective way in facilitating the country's goal in controlling Hepatitis B.China's Ministry of Health has also credited its national immunization program for having protected about 80 million people from being infected with the Hepatitis B virus (HBV) in the 19 years after 1992.Recent report showed that about 93 million Chinese are HBV carriers, accounting for more than a quarter of the world's total.

BEIJING, Oct. 18 (Xinhuanet) -- NASA recently unveiled its new rocket design, named Space Launch System (SLS), according to media reports.The rocket will make its first unmanned flight in 2017, and the flight with astronauts aboard won't happen until 2021, according to NASA's plan.The new rocket was 320 feet in length (the space shuttle was 184 feet on the launch pad), 5.5 million pounds in weight, and with the capacity of holding four astronauts at the top speed of 25,000 miles per hour, Washington Post reported Tuesday.Compared with space shuttle and other predecessors, the new rocket will aim for much farther destinations into the space with its most powerful engine ever built, according to the plan."We're investing in technologies to live and work in space, and it sets the stage for visiting asteroids and Mars," the NASA administrator Charles Bolden briefed the media at a news conference in Washington.NASA expected to devote 3 billion U.S. dollars a year to the effort, or a total of about 18 billion U.S. dollars over the next six years, said William Gerstenmaier, the agency’s associate administrator for human exploration.The current financial condition of U.S. may slow down the pace of progress, which will be much slower than NASA's Apollo heyday in the 1960s.

WELLINGTON, Oct. 26 (Xinhua) -- New Zealand's geothermal scientists will be collaborating with the world's leading geothermal researchers after the country joins an elite international group next month.New Zealand would be admitted to the International Partnership for Geothermal Technology (IPGT) in Melbourne, Australia, on Nov. 16, Science and Innovation Minister Wayne Mapp announced Wednesday."Geothermal energy is one of our most important renewable energy resources with huge potential for growth," said Mapp."This recognition of our geothermal research programs will allow our scientists to collaborate with an elite group of researchers in the United States, Australia, Switzerland and Iceland."Scientists from New Zealand research organizations were committed to finding new ways to harness the country's extensive geothermal fields, said Mapp."Innovation and clean energy is a big part of enabling New Zealand to grow the economy," said Mapp."This new international partnership will help keep us at the forefront of technology developments such as enhanced geothermal systems."Established in 2008, the IPGT seeks to develop advanced, cost- effective geothermal energy technologies through international research co-operation.New Zealand's geothermal electricity generation rose by 21 percent last year and accounted for 13 percent of total electricity generation, its highest recorded level.The government is aiming to expand geothermal energy with three large geothermal projects in the pipeline by 2020.The country's biggest geothermal project is to be Contact Energy's 250-megawatt Tauhara II geothermal project.The project, being developed northeast of the central North Island town of Taupo, is expected to produce enough electricity to meet the needs of around 270,000 homes when it becomes fully operational in 2015.